Biotech research firm Miltenyi Biotec disclosed a ransomware attack that took place in October and affected its IT infrastructure worldwide.
Biotech research firm Miltenyi Biotec was hit with a ransomware attack that took place in October and affected its IT infrastructure worldwide.
The company announced that it has fully restored systems after the attack, anyway in some countries local employees are still facing problems with mail and telephone systems.
Miltenyi Biotec is a global biotechnology company headquartered in Cologne, Germany, that provides products and services that support scientists, clinical researchers, and physicians across basic research, translational research, and clinical applications. The company offers solutions covering techniques of sample preparation, cell separation, cell sorting, flow cytometry, cell culture, molecular analysis, clinical applications and small animal imaging. Miltenyi Biotec has more than 3,000 employees in 28 countries and more than 17,000 products.
Miltenyi Biotec is providing the above products, including SARS-CoV-2 antigens, to clinicians and researchers who are working on COVID-19 vaccines and treatments.
“During the last two weeks, there have been isolated cases where order processing was impaired by malware in parts of our global IT infrastructure. Rest assured, all necessary measures have now been taken to contain the issue and recover all affected systems. Based on our current knowledge, we have no indication that the malware has been inadvertently distributed to customers or partners.” reads the announcement published by Miltenyi Biotec.
“As of this time, our operational processes have been fully restored. Should you have experienced any delays with your orders, we ask you to be patient for just a little longer, ..
Support the originator by clicking the read the rest link below.
